Tech Center 1600 • Art Units: 1637 1681
This examiner grants 36% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18190809 | SYSTEMS AND METHODS OF SEQUENCING POLYNUCLEOTIDES | Final Rejection | Illumina, Inc. |
| 17197836 | Nucleic Acid Sequence Analysis from Single Cells | Non-Final OA | Illumina, Inc. |
| 17415326 | COMPOSITIONS AND METHOD FOR SYNTHESIZING NUCLEIC ACIDS | Final Rejection | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 17470523 | COMBINED MULTIPLE-DISPLACEMENT AMPLIFICATION AND PCR IN AN EMULSION MICRODROPLET | Non-Final OA | The Regents of the University of California |
| 19326091 | COMPOSITIONS AND METHODS OF MAKING GENE EXPRESSION LIBRARIES | Final Rejection | 10x Genomics, Inc. |
| 17271866 | Methods for Generating Spatially Barcoded Arrays | Non-Final OA | 10x Genomics, Inc. |
| 17342327 | MICRONEEDLE-BASED RAPID ANALYTE EXTRACTION FROM PLANT AND ANIMAL TISSUES AND RELATED METHODS AND SYSTEMS | Non-Final OA | North Carolina State University |
| 17421677 | RAPID REVERSE TRANSCRIPTION QUANTITATIVE POLYMERASE CHAIN REACTION | Final Rejection | Northwestern University |
| 18027087 | RANDOM INSERTION GENOME RECONSTRUCTION | Final Rejection | GOOGLE LLC |
| 17621122 | DNA MARKERS FOR DIFFERENTIATION OF BIOPSY SAMPLES | Final Rejection | The Johns Hopkins University |
| 17294179 | CRISPR SYSTEM BASED DROPLET DIAGNOSTIC SYSTEMS AND METHODS | Non-Final OA | THE GENERAL HOSPITAL CORPORATION |
| 17925693 | METHODS FOR DETECTION OF DONOR-DERIVED CELL-FREE DNA | Final Rejection | Natera, Inc. |
| 17600789 | IMPROVED LIQUID BIOPSY USING SIZE SELECTION | Non-Final OA | Natera, Inc. |
| 17427394 | COST-EFFECTIVE DETECTION OF LOW FREQUENCY GENETIC VARIATION | Final Rejection | CHILDREN'S MEDICAL CENTER CORPORATION |
| 17441670 | SIGNATURE FOR DIAGNOSIS OF BACTERIAL VS VIRAL INFECTIONS | Final Rejection | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS |
| 17905784 | NOVEL NUCLEIC ACID TEMPLATE STRUCTURE FOR SEQUENCING | Final Rejection | Roche Sequencing Solutions, Inc. |
| 17422093 | A METHOD FOR DETERMINING THE SEVERITY OR GRADE OF HUMAN PAPILLOMAVIRUS (HPV)-INDUCED DYSPLASIA | Non-Final OA | Charité - Universitätsmedizin Berlin |
| 17434548 | ANALYTE DETECTION METHOD | Final Rejection | IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE |
| 17426057 | METHODS FOR PREDICTING A VERY LOW BIRTH WEIGHT | Non-Final OA | Imperial College of Science, Technology and Medicine |
| 17425611 | KIT FOR DETECTING MELANOMA | Final Rejection | Council of Scientific and Industrial Research |
| 18248285 | METHODS AND MEANS FOR AMPLIFICATION-BASED QUANTIFICATION OF NUCLEIC ACIDS | Non-Final OA | Imperial College Innovations Limited |
| 18265367 | DNA APTAMERS FOR THE DETECTION OF MONOMERIC CRP | Non-Final OA | Universiteit Hasselt |
| 17554181 | SYSTEMS FOR SAMPLE ANALYSIS | Non-Final OA | Biomeme, Inc. |
| 17580425 | COMPOSITIONS AND METHOD FOR DETECTING HUMAN PARVOVIRUS NUCLEIC ACID AND FOR DETECTING HEPATITIS A VIRUS NUCLEIC ACIDS IN SINGLE-PLEX OR MULTIPLEX ASSAYS | Non-Final OA | GEN-PROBE INCORPORATED |
| 18278664 | METHOD FOR DETERMINING PRIMARY TUMOR SITE | Non-Final OA | ONCOCROSS CO., LTD. |
| 16898550 | METHODS OF FETAL ABNORMALITY DETECTION | Non-Final OA | Verinata Health, Inc. |
| 18352651 | BIOCHIP AND METHOD FOR TRACKING POSTOPERATIVE RECURRENCE STATUS OF PATIENT WITH LUNG ADENOCARCINOMA | Non-Final OA | MacKay Medical College |
| 18066953 | COMPOSITIONS AND METHODS FOR DETECTION OF VARIANTS | Final Rejection | Twist Bioscience Corporation |
| 18313146 | METHODS FOR DETECTION OF NUCLEOTIDE MODIFICATION | Non-Final OA | BLUECAT IP LIMITED |
| 18031165 | MASSIVELY PARALLELED MULTI-PATIENT ASSAY FOR PATHOGENIC INFECTION DIAGNOSIS AND HOST PHYSIOLOGY SURVEILLANCE USING NUCLEIC ACID SEQUENCING | Non-Final OA | The USA, as represented by the Secretary, Dept. of Health and Human Services |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy